Key facts
- This page summarizes Franco Poletti's Form 4 filing for LivaNova PLC (LIVN).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Mar 2026, 17:25.
Franco Poletti - 11 Mar 2026 Form 4 Insider Report for LivaNova PLC (LIVN)
- Reporting relationship
- President, Cardiopulmonary
- Issuer ticker
- LIVN
- Reported as of
- 11 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Mar 2026, 17:25:31 UTC
- Prior SEC filing
- 17 Dec 2025
- Next SEC filing
- 01 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sarah K. Mohr, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Franco Poletti filed Form 4 for LivaNova PLC (LIVN) on 13 Mar 2026.
Change
- Previous filing in this sequence was filed on 17 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002031281
Primary reporting owner
Poletti Franco
- Relationship
- President, Cardiopulmonary
- Address
- 20 EASTBOURNE TERRACE, LONDON, UNITED KINGDOM
- Signature
- /s/ Sarah K. Mohr, Attorney-in-Fact
- Signature date
- 13 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIVN
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +2,140
- Change %
- +24%
- Price
- $57.60*
- Shares after
- 10,990
- Date
- 11 Mar 2026
- Ownership
- Direct
LIVN
transaction
Ordinary Shares
Tax liability
- Transaction value
- Shares
- -1,980
- Change %
- -18%
- Price
- $62.26*
- Shares after
- 9,010
- Date
- 11 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
LIVN
transaction
Ordinary Shares
Tax liability
- Transaction value
- Shares
- -69
- Change %
- -0.77%
- Price
- $62.26*
- Shares after
- 8,941
- Date
- 11 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
LIVN
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 219
- Date
- 11 Mar 2026
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LIVN
transaction
Derivative
Stock Appreciation Rights
Options Exercise
- Transaction value
- Shares
- -2,140
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 11 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,140
- Exercise price
- $57.60
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares withheld for stock appreciation right ("SAR") base price settlement.
Footnote F2
Shares withheld to satisfy tax liability.
Footnote F3
Reporting person was granted SARs on March 11, 2016 that vested in four equal annual installments beginning March 11, 2017 under the LivaNova PLC 2015 Incentive Award Plan and were automatically exercised upon their March 11, 2026 expiration date.